Rising incidences of adverse drug reactions and resistance to the treatments in patients, coupled with high investment in the study of pharmacogenomics, is driving the market growth.
The Global Pharmacogenomics specific Market size is forecasted to reach USD 11.01 billion from USD 5.66 billion in 2019, delivering a CAGR of 8.7% through 2027. The market growth is driven...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian